Application

Anti-Amyloid β Precursor Protein Antibody, KPI domain, clone 4.1 detects level of Amyloid β Precursor Protein & has been published & validated for use in ELISA, WB, IH.

Western blot: 2-5 µg/mL using ECL on human brain or platelets. Recognizes a protein of 100-120 kDa.

Immunohistochemistry: 2-5 µg/mL on frozen tissue sections.

ELISA: 1 µg/mL in a direct assay and 10 µg/mL in an indirect assay.

Optimal working dilutions must be determined by the end user.

Research Sub CategoryNeurodegenerative Diseases

Research CategoryNeuroscience

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Immunogen

Epitope: KPI domain

Purified recombinant KPI domain of Amyloid-beta precursor protein.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Physical form

Purified immunoglobulin. Liquid in 20 mM Sodium phosphate buffer with 150 mM NaCl.

Format: Purified

Specificity

Amyloid-beta Precursor Protein, KPI (Kunitz protease inhibitor) domain. The antibody reacts with both native and recombinant protein. The antibody has been shown to partially inhibit protease inhibitory properties.

Storage and Stability

Maintain at 2-8°C in undiluted aliquots for up to 6 months of date of receipt.